WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013117742) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/117742    International Application No.:    PCT/EP2013/052615
Publication Date: 15.08.2013 International Filing Date: 08.02.2013
IPC:
C07K 14/435 (2006.01), C07K 14/47 (2006.01), A61K 39/00 (2006.01), A61K 9/70 (2006.01)
Applicants: SELMAJ, Krzysztof [PL/PL]; (PL).
SZCZEPANIK, Marian [PL/PL]; (PL)
Inventors: SELMAJ, Krzysztof; (PL).
SZCZEPANIK, Marian; (PL)
Agent: WITEK, Rafał; WTS Patent Attorneys Witek, Śnieżko & Partners Weigla 12 PL-53-114 Wrocław (PL)
Priority Data:
PL398077 10.02.2012 PL
Title (EN) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
(FR) COMPOSITION PHARMACEUTIQUE DESTINÉE AU TRAITEMENT DE LA SCLÉROSE MULTIPLE
Abstract: front page image
(EN)The subject of the present invention is pharmaceutical composition containing active ingredients in the form of a peptide of the myelin basic protein, a peptide from the myelin protein and oligodendrocytes as well as a peptide of the proteolipid protein as well as the use of the composition in the manufacturing of a drug for topical administration in the treatment of the disease multiple sclerosis. The composition may be administered topically.
(FR)La présente invention concerne une composition pharmaceutique contenant des principes actifs sous forme d'un peptide de la protéine basique de la myéline, un peptide de la protéine de la myéline et d'oligodendrocytes, ainsi qu'un peptide de la protéine protéolipide. L'invention porte également sur l'utilisation de ladite composition dans la fabrication d'un médicament pour administration topique dans le traitement de la sclérose en plaques. Ladite composition peut être administrée par voie topique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)